Optical Chip Test for T Cell Function in HIV Patients

Information

  • Research Project
  • 6843406
  • ApplicationId
    6843406
  • Core Project Number
    R44AI048318
  • Full Project Number
    2R44AI048318-04A1
  • Serial Number
    48318
  • FOA Number
    PA-01-52
  • Sub Project Id
  • Project Start Date
    7/1/2000 - 25 years ago
  • Project End Date
    8/31/2006 - 19 years ago
  • Program Officer Name
    LIVNAT, DANIELLA
  • Budget Start Date
    9/1/2004 - 21 years ago
  • Budget End Date
    8/31/2005 - 20 years ago
  • Fiscal Year
    2004
  • Support Year
    4
  • Suffix
    A1
  • Award Notice Date
    8/12/2004 - 21 years ago
Organizations

Optical Chip Test for T Cell Function in HIV Patients

[unreadable] DESCRIPTION (provided by applicant): This proposal is targeted at the development of a novel research platform for analyzing immune cell gene expression as a result of HIV infection that is based on the on-chip real-time amplification detection (OCRAD) method that came out of the Phase I program. Current methods for performing gene expression analysis require lengthy and complex protocols, involving separate RNA amplification, hybridization, washing and label read-out steps. OCRAD employs a refractometric integrated optic chip (IOC) sensor to perform multiplex on-chip nucleic acid amplification. This combination of on-chip amplification and real-time detection will create a platform with the features necessary to make a significant advancement in the ability of researchers to perform gene expression measurements in a more rapid, simple and less expensive format. Gene expression analysis is an important tool for understanding a cell's differentiation state and may be useful in a clinical setting as a diagnostic or predictive tool. CD8 T cells are critical for the control of many viral infections and are the target of vaccine efforts for HIV. However, during HIV infection immune control by CD8 T cells eventually fails leading to AIDS. Considerable evidence suggests that CD8 T cells in HIV patients undergo an inappropriate differentiation process leading to impaired function, although the molecular signature of this process in humans is not well defined. Using a small gene set profile based on previous gene expression studies using mouse models of viral infection, OCRAD will be applied to analyzing gene expression in CD8 T cell subsets from HIV- healthy patients, HIV+ patients with suppressed viral load and HIV+ patients with viremia. It is believed that this analysis should provide a better understanding of the molecular profile of CD8 T cells during HIV infection. This may ultimately lead to improved diagnostic and/or predictive clinical tools and may uncover important biological pathways that can be used as targets for therapeutic intervention. [unreadable] [unreadable]

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R44
  • Administering IC
    AI
  • Application Type
    2
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    836212
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    856
  • Ed Inst. Type
  • Funding ICs
    NIAID:836212\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    NGIMAT COMPANY
  • Organization Department
  • Organization DUNS
  • Organization City
    ATLANTA
  • Organization State
    GA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    30341
  • Organization District
    UNITED STATES